Search Orphan Drug Designations and Approvals
-
| Generic Name: | selective small molecule messenger RNA (mRNA) degrader of MYB |
|---|---|
| Date Designated: | 04/24/2024 |
| Orphan Designation: | Treatment of acute myeloid leukemia (AML) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Remix Therapeutics 100 Forge Rd., Suite 400 Watertown, Massachusetts 02472 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







